Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) | PAR-24-099 | NIAID | This Notice of Funding Opportunity (NOFO) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to implement investigator-initiated… More | ||
| Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional) | RFA-AR-25-002 | NIAMS | Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional) | ||
| Limited Competition: Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial Not Allowed) | PAS-21-245 | NIAMS | Promoting a Basic Understanding of Chemical Threats to Skin (R34 Clinical Trial not allowed) | ||
| Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) | PAR-22-119 | NIAMS | Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) | ||
| Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed) | PAR-23-032 | NIAMS | Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not… More | ||
| Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) | PAR-23-025 | NIAMS | Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed) | ||
| Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) | PAR-23-026 | NIAMS | Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) | ||
| Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) | PAR-24-035 | NIAMS | Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) | ||
| Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) | PAR-24-036 | NIAMS | Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) | ||
| Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) | PAR-22-123 | NIBIB | This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising… More |